IBRANCE Drug Profile, 2020

$499.00

IBRANCE Drug Profile, 2020

This report focuses on IBRANCE and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 207103 Category:

Description

Copyright © DrugPatentWatch. Originally published at IBRANCE Drug Profile, 2020

IBRANCE Drug Profile, 2020

This report focuses on IBRANCE and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for IBRANCE
  • US Patents
  • US Regulatory Exclusivity
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Finished Product Suppliers
  • Bulk API Sources

    Make Better Decisions with DrugPatentWatch

    Get the Daily Briefing or Try a trial

    Copyright © DrugPatentWatch. Originally published at IBRANCE Drug Profile, 2020